EMA Authorised: Lumeblue (previously Methylthioninium chloride Cosmo) (methylthioninium chloride) — Cosmo Technologies Ltd

View source ↗

Summary

Lumeblue, containing methylthioninium chloride, has been authorised by the EMA for use in colorectal neoplasms and during colonoscopy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• Lumeblue (methylthioninium chloride)

Snippet

Status: Authorised. Therapeutic area: Colorectal Neoplasms;Colonoscopy. MAH: Cosmo Technologies Ltd. Decision date: 22/05/2025